Synapse Open Synapse
Biology

Bristol Myers dips on ‘confounding’ lung drug results

BioPharma Dive · · 2 min read

Only the lower of two tested doses of the idiopathic pulmonary fibrosis drug admilparant met the trial’s main objective, adding to analyst questions about the therapy’s prospects.

Latest from BioPharma Dive